GLP-1: Molecular mechanisms and outcomes of a complex signaling system
- PMID: 31002893
- PMCID: PMC7081944
- DOI: 10.1016/j.neuint.2019.04.010
GLP-1: Molecular mechanisms and outcomes of a complex signaling system
Abstract
Meal ingestion provokes the release of hormones and transmitters, which in turn regulate energy homeostasis and feeding behavior. One such hormone, glucagon-like peptide-1 (GLP-1), has received significant attention in the treatment of obesity and diabetes due to its potent incretin effect. In addition to the peripheral actions of GLP-1, this hormone is able to alter behavior through the modulation of multiple neural circuits. Recent work that focused on elucidating the mechanisms and outcomes of GLP-1 neuromodulation led to the discovery of an impressive array of GLP-1 actions. Here, we summarize the many levels at which the GLP-1 signal adapts to different systems, with the goal being to provide a background against which to guide future research.
Keywords: Bariatric surgery; Feeding behavior; Glucagon-like peptide-1; Reward.
Copyright © 2019. Published by Elsevier Ltd.
Figures

Similar articles
-
Therapies for inter-relating diabetes and obesity - GLP-1 and obesity.Expert Opin Pharmacother. 2014 Dec;15(17):2487-500. doi: 10.1517/14656566.2014.965678. Epub 2014 Sep 26. Expert Opin Pharmacother. 2014. PMID: 25260877 Review.
-
Dopamine signaling in the amygdala, increased by food ingestion and GLP-1, regulates feeding behavior.Physiol Behav. 2014 Sep;136:135-44. doi: 10.1016/j.physbeh.2014.02.026. Epub 2014 Feb 21. Physiol Behav. 2014. PMID: 24560840
-
Diabetes and obesity treatment based on dual incretin receptor activation: 'twincretins'.Diabetes Obes Metab. 2016 Sep;18(9):847-54. doi: 10.1111/dom.12685. Epub 2016 Jun 7. Diabetes Obes Metab. 2016. PMID: 27160961 Review.
-
Impaired cardiometabolic responses to glucagon-like peptide 1 in obesity and type 2 diabetes mellitus.Basic Res Cardiol. 2013 Jul;108(4):365. doi: 10.1007/s00395-013-0365-x. Epub 2013 Jun 14. Basic Res Cardiol. 2013. PMID: 23764734 Free PMC article. Clinical Trial.
-
Glucagon-Like Peptide-1 (GLP-1) in the Integration of Neural and Endocrine Responses to Stress.Nutrients. 2020 Oct 28;12(11):3304. doi: 10.3390/nu12113304. Nutrients. 2020. PMID: 33126672 Free PMC article. Review.
Cited by
-
Effect of Combined Antiretroviral Therapy on the Levels of Selected Parameters Reflecting Metabolic and Inflammatory Disturbances in HIV-Infected Patients.J Clin Med. 2022 Mar 19;11(6):1713. doi: 10.3390/jcm11061713. J Clin Med. 2022. PMID: 35330038 Free PMC article.
-
GLP-1 Induces the Expression of FNDC5 Derivatives That Execute Lipolytic Actions.Front Cell Dev Biol. 2021 Nov 11;9:777026. doi: 10.3389/fcell.2021.777026. eCollection 2021. Front Cell Dev Biol. 2021. PMID: 34869379 Free PMC article.
-
Targeting fibrosis, mechanisms and cilinical trials.Signal Transduct Target Ther. 2022 Jun 30;7(1):206. doi: 10.1038/s41392-022-01070-3. Signal Transduct Target Ther. 2022. PMID: 35773269 Free PMC article. Review.
-
An alternative pathway for sweet sensation: possible mechanisms and physiological relevance.Pflugers Arch. 2020 Dec;472(12):1667-1691. doi: 10.1007/s00424-020-02467-1. Epub 2020 Oct 8. Pflugers Arch. 2020. PMID: 33030576 Review.
-
Effects of miR-33 Deficiency on Metabolic and Cardiovascular Diseases: Implications for Therapeutic Intervention.Int J Mol Sci. 2023 Jun 28;24(13):10777. doi: 10.3390/ijms241310777. Int J Mol Sci. 2023. PMID: 37445956 Free PMC article. Review.
References
-
- Ahrén B, 2004. Sensory nerves contribute to insulin secretion by glucagon-like peptide-1 in mice. Am. J. Physiol. Integr. Comp. Physiol 286, R269–R272. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources